Pathology services at Barnsley Hospital are part of the South Yorkshire and Bassetlaw Pathology partnership.
Biotin (vitamin B7) is an essential nutrient naturally present in the diet. The required daily intake of biotin is quite small (30-70 micrograms), and most diets will contain sufficient amounts. Multivitamin supplements also often contain biotin in these small amounts.
Higher dose biotin supplements (5-10mg, sometimes higher) are available over-the-counter, marketed for hair, skin and nail health, and also sometimes prescribed as a treatment for multiple sclerosis or some inherited metabolic disorders. These can potentially interfere with some biochemistry tests called “immunoassays”.
Biotin interference can cause falsely high or low results depending on the design of the immunoassays. Competitive assays may give falsely high results, and sandwich assays may give falsely low results.
Rotherham and Barnsley Hospitals use the Siemens Atellica platform for their blood tests. These assays are generally quite resistant to biotin interferences, even at high biotin concentrations. Siemens have however identified some of their assays which may be affected in patients taking high dose biotin supplements (at least 5-10mg/d):
Assay | Assay design | Possible result interference |
Serum folate | Competitive immunoassay | Falsely increased |
Brain natriuretic peptide (BNP) | Sandwich immunoassay | Falsely decreased |
Pro N-terminal brain natriuretic peptide (Pro-NT BNP) | Sandwich immunoassay | Falsely decreased |
Erythropoietin (EPO) | Sandwich immunoassay | Falsely decreased |
Sex hormone binding globulin (SHBG) | Sandwich immunoassay | Falsely decreased |
Testosterone | Competitive immunoassay | Falsely increased |
The half-life of biotin varies significantly depending on the dose taken and the dosing schedule, and other factors such as the patient’s renal function. If you are planning a non-urgent test for a patient taking biotin therapy (at a dose of 5mg or higher) which can be safely stopped, the biotin should be stopped for 1 week before testing. If the patient cannot safely stop taking the biotin, or testing is required within 1 week of their last dose, please contact the Duty Biochemist via Switchboard to discuss.
References:
- Biotin interference in certain immunoassays (Atellica IM Analyzer), Siemens Healthineers Customer Bulletin, September 2019.
- Avery G. Biotin interference in immunoassay: a review for the laboratory scientist. Annals of Clinical Biochemistry. 2019;56(4):424-430. doi:10.1177/0004563219842231